Add 2 More Reports For 20% off

Report Overview

The global periodontal therapeutics market size attained a value of USD 3.07 billion in 2023, driven by growing incidence of diabetes. The market is anticipated to grow at a CAGR of 8.7% during the forecast period of 2024-2032 to attain a value of USD 6.49 billion by 2032.

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Periodontal Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Segmentation

Periodontal diseases that trigger the destruction of the dentition supporting structures are prevalent chronic oral cavity infectious diseases. The periodontal therapeutics market can be divided on the basis of segments like:

Market Breakup by Product

  • Systemic Antibiotics
  • Local Antibiotics

Market Breakup by Treatment Type

  • Non-Surgical Treatment
  • Surgical Treatment

Market Breakup by Disease Type

  • Gingivitis
  • Chronic Periodontal Disease
  • Aggressive Periodontal Disease
  • Others

Market Breakup by End User

  • Hospitals
  • Dental Clinics
  • Dental Academics and Research Institutes
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Periodontal Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

The growing incidence of diabetes is driving the global periodontal therapeutics market. Due to product affordability, accessibility, and elevated industry penetration, systemic antibiotics held the most significant share in the periodontal therapeutics market. They would further drive the periodontal therapeutics market growth during the forecast period. The rising incidence of periodontal diseases owing to a sedentary lifestyle, an effective reimbursement scenario, and an increasing geriatric population are the key drivers for the growth of the North American market for periodontal therapeutics.

Global Periodontal Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

The report presents a detailed analysis of the following key players in the global periodontal therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • 3M Company        
  • Den-Mat Holdings, LLC  
  • Dexcel Ltd.
  • Kaken Pharmaceutical Co., Ltd.      
  • Bausch Health Companies Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

In 2023, the global market periodontal therapeutics attained a value of USD 3.07 billion.

The market is anticipated to grow at a CAGR of 8.7% during the forecast period of 2024-2032 to reach a value of USD 6.49 billion by 2032.

The rising incidence of diabetes along with the affordability and accessibility of the therapeutic products and services are the major driver for the global market.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America has been leading the global market.

The products in the market include systemic antibiotics and local antibiotics.

The treatment types include non-surgical treatment and surgical treatment.

The disease types can be categorised into gingivitis, chronic periodontal disease, and aggressive periodontal disease, among others.

The end-users include hospitals, dental clinics, dental academics and research institutes, among others.

Key players involved in the market are 3M Company, Den-Mat Holdings, LLC, Dexcel Pharma, Kaken Pharmaceutical Co., Ltd., Bausch Health Companies Inc., Colgate-Palmolive Company (India) Limited, Mylan N.V., Pfizer Inc, Noveome Biotherapeutics, Inc., and WOCKHARDT.

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Treatment Type
  • Disease Type
  • End User
  • Region
Breakup by Product
  • Systemic Antibiotics
  • Local Antibiotics
Breakup by Treatment Type
  • Non-Surgical Treatment
  • Surgical Treatment
Breakup by Disease Type
  • Gingivitis
  • Chronic Periodontal Disease
  • Aggressive Periodontal Disease
  • Others
Breakup by End User
  • Hospitals
  • Dental Clinics
  • Dental Academics and Research Institutes
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • 3M Company
  • Den-Mat Holdings, LLC
  • Dexcel Pharma
  • Kaken Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc.
  • Colgate-Palmolive Company (India) Limited
  • Mylan N.V.
  • WOCKHARDT
  • Pfizer Inc
  • Noveome Biotherapeutics, Inc
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124